Publicaciones en colaboración con investigadores/as de Centre National de la Recherche Scientifique (19)

2024

  1. Acute and two-week effects of neotame, stevia rebaudioside M and sucrose-sweetened biscuits on postprandial appetite and endocrine response in adults with overweight/obesity—a randomised crossover trial from the SWEET consortium

    eBioMedicine, Vol. 102

2015

  1. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles

    Journal of Pharmaceutical Sciences, Vol. 104, Núm. 9, pp. 2877-2886

  2. Strict requirement for vector-induced type I interferon in efficacious antitumor responses to virally encoded IL12

    Cancer Research, Vol. 75, Núm. 3, pp. 497-507

2014

  1. Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming

    Journal of Immunology, Vol. 193, Núm. 3, pp. 1151-1161

2012

  1. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 81, Núm. 3, pp. 514-523

2011

  1. Cardiotrophin-1 is a key regulator of glucose and lipid metabolism

    Cell Metabolism, Vol. 14, Núm. 2, pp. 242-253

2008

  1. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 70, Núm. 1, pp. 98-108

2006

  1. The protein kinase IKKε can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers

    Hepatology, Vol. 44, Núm. 6, pp. 1635-1647

2003

  1. Polymeric carriers for amphotericin B: In vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 3, pp. 419-427

1998

  1. Interaction of amphotericin B with polymeric colloids a spectroscopic study

    Colloids and Surfaces B: Biointerfaces, Vol. 11, Núm. 3, pp. 141-151

1997

  1. Characterization and morphological analysis of a cholecystokinin derivative peptide-loaded poly(lactide-co-glycolide) microspheres prepared by a water-in-oil-in-water emulsion solvent evaporation method

    Journal of Controlled Release, Vol. 43, Núm. 1, pp. 81-87

  2. Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides

    Advanced Drug Delivery Reviews, Vol. 28, Núm. 1, pp. 85-96

1996

  1. Slow delivery of the selective cholecystokinin agonist pBC 264 into the rat nucleus accumbens using microspheres

    Journal of Neurochemistry, Vol. 67, Núm. 6, pp. 2417-2424

  2. Study of the influence of several stabilizing agents on the entrapment and in vitro release of pBC 264 from Poly(lactide-co-glycolide) microspheres prepared by a W/O/W solvent evaporation method

    Pharmaceutical Research, Vol. 13, Núm. 7, pp. 1127-1129

1995

  1. Mucin interactions with functionalized polystyrene latexes

    Journal of Colloid And Interface Science, Vol. 170, Núm. 2, pp. 555-561

1994

  1. Characterization of V3 BRU peptide-loaded small PLGA microspheres prepared by a (w1/o)w2 emulsion solvent evaporation method

    International Journal of Pharmaceutics, Vol. 111, Núm. 2, pp. 137-145

  2. EX-VIVO STUDY OF LATEX ADSORPTION ON INTESTINAL-MUCOSA

    IN VITRO AND EX VIVO TEST SYSTEMS TO RATIONALIZE DRUG DESIGN AND DELIVERY

  3. Mucoadhesion of Latexes. II. Adsorption Isotherms and Desorption Studies

    Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists, Vol. 11, Núm. 5, pp. 680-683

  4. STUDY OF THE INTERACTIONS BETWEEN NANOPARTICLES AND INTESTINAL MUCOSA

    TRENDS IN COLLOID AND INTERFACE SCIENCE VIII